$131.32
-0.71-0.54%
At close: -
$128.75
-2.57-1.96%
After Hours: 7:32 PM EDT
Comments
Loading...
Latest Biogen Stock News | NASDAQ:BIIB | Benzinga
Get the latest news on Biogen stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Biogen performance
Categories: All
Wednesday, April 02, 2025
Tuesday, April 01, 2025
Friday, March 28, 2025
Monday, March 24, 2025
Friday, March 21, 2025
Wednesday, March 19, 2025
Tuesday, March 11, 2025
Monday, March 10, 2025
Friday, March 07, 2025
Thursday, March 06, 2025
Tuesday, March 04, 2025
Monday, March 03, 2025
Friday, February 28, 2025
Monday, February 24, 2025
Friday, February 21, 2025
Tuesday, February 18, 2025
Thursday, February 13, 2025
- Leqembi And Skyclarys Expected To Drive Biogen's Future Growth: Analysts
- Scotiabank Maintains Sector Outperform on Bio...
- BMO Capital Maintains Market Perform on Bioge...
- Morgan Stanley Maintains Equal-Weight on Biog...
- Goldman Sachs Maintains Buy on Biogen, Lowers...
- RBC Capital Maintains Outperform on Biogen, L...
- Citigroup Maintains Neutral on Biogen, Lowers...
- Wells Fargo Maintains Equal-Weight on Biogen,...
- Biogen Analysts Lower Their Forecasts After Q4 Results
- HC Wainwright & Co. Maintains Buy on Biogen, ...
- Truist Securities Maintains Buy on Biogen, Lo...
- Forecasting The Future: 10 Analyst Projections For Biogen
- Canaccord Genuity Maintains Buy on Biogen, Lo...
- Needham Reiterates Hold on Biogento Hold
Wednesday, February 12, 2025
- Biogen Delivers Q4 Beat, Analyst Focuses On Leqembi Expansion, 2025 Outlook
- Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?
- Biogen shares are trading lower after the com...
- Biogen Q4 Earnings: Revenue And EPS Beat, Warns Lower 2025 Revenue, Inks R&D Funding Pact With Royalty Pharma
- Biogen Forecasts FY2025 Adjusted EPS Of $15.2...
- Biogen Q4 2024 Adj EPS $3.44 Beats $3.35 Esti...
- Royalty Pharma Entered Into An Agreement With...
- US Stocks Set For A Cautious Start Ahead Of Inflation Data: Expert Says 'Strong Bull Markets Tend To Roar Back To Life After Corrections'
- Earnings Scheduled For February 12, 2025
- Biogen Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts